Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression
Abstract Exosomes are involved in a wide range of biological processes in human cells. Considerable evidence suggests that engineered exosomes (eExosomes) containing therapeutic agents can attenuate the oncogenic activity of human cancer cells. Despite its biomedical relevance, no information has be...
Guardado en:
Autores principales: | Yutaro Kase, Katsuhiro Uzawa, Sho Wagai, Shusaku Yoshimura, Jun-Ichiro Yamamoto, Yuriko Toeda, Megumi Okubo, Keitaro Eizuka, Toshiaki Ando, Takafumi Nobuchi, Kohei Kawasaki, Tomoaki Saito, Manabu Iyoda, Dai Nakashima, Atsushi Kasamatsu, Hideki Tanzawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ed74c814c914ce78df8087aa1a83150 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer
por: Toshiaki Ando, et al.
Publicado: (2021) -
RNAi Crop Protection Advances
por: Alejandro Hernández-Soto, et al.
Publicado: (2021) -
Progress on RNAi-based molecular medicines
por: Chen J, et al.
Publicado: (2012) -
Study on RNAi-based herbicide for Mikania micrantha
por: Jiantao Mai, et al.
Publicado: (2021) -
Bacterial-mediated RNAi and functional analysis of Natalisin in a moth
por: Xia-Fei Wang, et al.
Publicado: (2021)